Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001671584-25-000001
Filing Date
2025-04-18
Accepted
2025-04-18 12:22:13
Documents
1
Effectiveness Date
2025-04-18
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4876
  Complete submission text file 0001671584-25-000001.txt   6040
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-544060 | Film No.: 25849666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)